KBI Biopharma

KBI Biopharma, a subsidiary of JSR Life Sciences, is a prominent global contract development and manufacturing organization (CDMO) that offers fully integrated drug development and biologics manufacturing services to life science companies. Working closely with over 500 client partners, KBI customizes and expedites drug development programs. With top-notch analytical capabilities and extensive scientific expertise, KBI provides robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs, positioning itself as a leader in quality manufacturing. KBI has multiple facilities in Europe and the USA to support its global clientele. Selexis SA, also a part of JSR Life Sciences, is the foremost company in cell line development, offering modular technology and specialized solutions to accelerate the discovery, development, and commercialization of innovative medicines and vaccines in the life sciences industry. Utilized by global client partners, Selexis technologies have advanced over 160 drug candidates and manufactured ten commercial products. These technologies play a crucial role in shortening development timelines and reducing manufacturing risks in the comprehensive drug development process.